Boston Financial Closes Lease for Seattle Drug Discovery Co.



Boston Financial & Equity started off 2020 by closing a lease transaction with a Seattle-based drug discovery company for a $725,000 fermentation system.

The company founded in 2011, originally funded by family and friends, has raised over $29 million to date.

Its approach to drug discovery accelerates the timeline and increases manufacturing efficiencies, reducing the costs to the biopharmaceutical industry.

Although the company has less than a year of cash and minimal revenues, it has agreements with three of the largest pharma companies. 

Leave a comment

View Latest Digital Edition

Terry Mulreany
Subscriptions: 800 708 9373 x130
terry.mulreany@monitordaily.com
Susie Angelucci
Advertising: 484.459.3016
susie.angelucci@monitordaily.com

View Latest Digital Edition

Visit our sister website for news, information, exclusive articles,
deal tables and more on the asset-based lending, factoring,
and restructuring industries.
www.abfjournal.com